Electronic Pill Helps Combat Obesity Eating Disorders
By HospiMedica International staff writers Posted on 06 May 2015 |
Image: The prototype Melcap capsule (Photo courtesy of Melcap).
A prototype electronic capsule delivers electrical stimulation to the muscles of the stomach wall, giving the patient a feeling of satiety and reducing their urge for food intake.
The MelCap system is comprised of three main parts; a remotely controlled capsule adapted for ingestion or placement into the gastrointestinal tract (GT); a remote control device or smartphone for controlling and sharing information with the capsule; and a magnetic coupling system for fixing the capsule within the GI tract of the patient. The capsule, the size of a large pill, is first swallowed by the patient. Upon arrival into the stomach, it absorbs stomach fluids, increasing its size, enabling it to remain in place and operate continuously.
Once in place, the magnetic coupling system is used to position it in the specific spot selected within the stomach, be it near the lower esophagus sphincter (LES) or in proximity to the vagus nerve. The pill unfurls a mesh filled with inflated particles and the wireless device is then used to activate the pill. When it receives the signal, the pill delivers a series of electrical pulses to stimulate the lining of the stomach. Depending on the pill’s location, different effects can be achieved to tailor the therapy to individual patient needs.
These could include, for example, gastric electrical stimulation (GES), LES muscle simulation, or vagus nerve blocking. The capsule continues to deliver electrical stimulation for up to 21 days, continuously monitored and controlled remotely by the wireless device. When exhausted, some of the biologic components are absorbed, while the electronic components are expelled from the system. The MelCap system is a product of Melcap (Ramat Gan, Israel).
Related Links:
Melcap
The MelCap system is comprised of three main parts; a remotely controlled capsule adapted for ingestion or placement into the gastrointestinal tract (GT); a remote control device or smartphone for controlling and sharing information with the capsule; and a magnetic coupling system for fixing the capsule within the GI tract of the patient. The capsule, the size of a large pill, is first swallowed by the patient. Upon arrival into the stomach, it absorbs stomach fluids, increasing its size, enabling it to remain in place and operate continuously.
Once in place, the magnetic coupling system is used to position it in the specific spot selected within the stomach, be it near the lower esophagus sphincter (LES) or in proximity to the vagus nerve. The pill unfurls a mesh filled with inflated particles and the wireless device is then used to activate the pill. When it receives the signal, the pill delivers a series of electrical pulses to stimulate the lining of the stomach. Depending on the pill’s location, different effects can be achieved to tailor the therapy to individual patient needs.
These could include, for example, gastric electrical stimulation (GES), LES muscle simulation, or vagus nerve blocking. The capsule continues to deliver electrical stimulation for up to 21 days, continuously monitored and controlled remotely by the wireless device. When exhausted, some of the biologic components are absorbed, while the electronic components are expelled from the system. The MelCap system is a product of Melcap (Ramat Gan, Israel).
Related Links:
Melcap
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure